Clinical Trials Logo

Haemolysis Neonatal clinical trials

View clinical trials related to Haemolysis Neonatal.

Filter by:
  • None
  • Page 1

NCT ID: NCT03130517 Not yet recruiting - Haemolysis Neonatal Clinical Trials

Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease

IVIG
Start date: July 1, 2017
Phase: Early Phase 1
Study type: Interventional

hemolytic disease of newborn is an important cause of hyperbilirubinemia with significant morbidity and mortality in neonatal period. intravenous immunoglobulin has widely used in management of hemolytic disease of new born